You are here: Industry Insights > Biotherapeutics

News List

Live Biotherapeutics: Targeting The Microbiome For The Cancer Treatment Shruti Talashi
March 18, 2024
The quest to create microbial products that can influence cancer outcomes has been rekindled by the mounting evidence of the role that microbiota plays in human health and illness.
Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs prnasia
December 09, 2021
Servatus Ltd, an unlisted Australian biopharmaceutical company and global expert in the identification and development of novel autoimmune therapies using live microbial biotherapeutics and engineered proteins...
Fujifilm Establishes U.S. Bio Center ContractPharma
December 11, 2019
To start full-scale translational research for biotherapeutics in the U.S.
Evotec Acquires Biotherapeutics contractpharma
July 04, 2019
$90M deal expands Evotec’s U.S. footprint in Seattle and machine learning capabilities.
Evotec to Acquire Just Biotherapeutics in $90M Transaction contractpharma
May 29, 2019
Expands therapeutic offerings in areas such as oncology, CNS, pain, inflammation, metabolics, and infectious diseases.
Protalix BioTherapeutics Appoints President, CEO contractpharma
May 29, 2019
Bashan brings more than 20 years of experience in the pharmaceutical industry.
Abzena Invests $20M to Expand Integrated Biotherapeutics Offering contractpharma
November 12, 2018
Abzena Invests $20M to Expand Integrated Biotherapeutics Offering
Cancer Research UK launches new research hub for biotherapeutics pharmaceutical-technology
September 20, 2018
Cancer Research UK has launched a global centre of excellence in London to facilitate research on biotherapeutics as a treatment option for cancer.
CR UK invests £14m in London cancer biotherapeutics hub pharmatimes
September 20, 2018
Cancer Research UK is investing some £14 million into transforming the city of London into a “world-leading hub for cancer biotherapeutics”.
BioGenes Celebrates 25 Years of Excellence in Quality Control of Biotherapeutics b3cnewswire
July 26, 2017
BioGenes GmbH, specializing in ELISA development and production, is celebrating its 25-year anniversary.

Previous page 1 2 Next page